EVA ORTEGA – Scientific Director at CNIO Biobank (Spanish National Cancer Research Centre)
Eva Ortega has more than 25 years’ work-experience in Industry, Academia and at the Health Care Sector. Extensive experience in Research Coordination and Project Management in Innovation Programs and Biobanking at National and International level. Great knowledge in Immunology, Oncology and Biobanking. Outstanding communication and interpersonal skills. Open, positive, fast problem-solving individual with a great capacity for engaging stakeholders and with a keen eye for detail.
2002: PhD in Chemistry (Biochemistry and Molecular Biology) Universidad Complutense. Madrid.Spain
1990-1995: BSc in Chemistry (Biochemistry and Molecular Biology). Universidad Complutense. Madrid. Spain
Sep 2019- to present: Scientific Director at CNIO Biobank (Spanish National Cancer Research Centre)
Feb 2018- to Sep 2019: Regional (Scania) Scientific and Biobank Coordinator and Representative of the Medical Faculty at Lund University in Biobank Sweden. Department of Enviromental and Occupational Medicine and Region Skåne Biobank Department BD47. Lund University. Sweden.
Feb 2013- Jan 2018: Coordinator of BBMRI.se Service Centre for Southern Sweden (http://www.med.lu.se/bbmri). Department of Immunotechnology. Lund University. Sweden.
Sep 2016- Dec 2017: Project Leader CIT (Clinical Innovation and Transformation) at SWElife. LU Innovation (www.swelife.se). Lund University. Sweden
– Project leader in a national strategic innovation program for innovation in the Health Care Sector in:
- Personalized Medicine in Cancer.
- Standardization and Integration of Biobanks in the Health Care Sector
2012- 2013: Self-employed. Coordinator for patient recruitment and collaboration between Sweden- Spain in IVF. (Clínica Vistahermosa. Alicante)
Spanish/English teacher in Compulsory Education (Grundskola.Emanuelskola. Sjöbo. Sweden)
2010- 2011: Senior Applications Manager at Noricon AB – Development of an ELISA-assay for early detection of Salmonella
2008 -2009: Senior Scientist. In Vitro Biology Group. Affitech AS. Oslo. Norway
- In vitro studies for validation of antibodies for therapeutic purposes
2004-2007: Scientist. Immunotechnology. LTH; Lund University. Sweden – Study of the functional implication of different genes by means of RNA interference on Mantle Cell Lymphoma cell lines.
2002 -2004: Guest researcher (Post doc) at Immunotechnology Department. Lund University. Sweden.
– Study of the functional implication of different genes by means of RNA interference on Mantle Cell Lymphoma cell lines
1995-2002: PhD Student: Postgraduate research grants from the state and biopharma. Immunology department (Immunochemistry Section). Hospital Ramon y Cajal. Madrid. Spain – Effect of lauryl gallate on PTKs and PTPs, cell lines and chemically-induced skin tumours in mice and radioactive synthesis of 14C-lauryl gallate.
1991-1996: Administrative Officer. Admissions Department Hospital Ramon y Cajal. Madrid
– Management and planning for activity at the Operating Theatres – Management of bed availability at the different Units at the hospital – Admission at the Emergency Department and management of bed availability in emergency situations.
2019- to present: Secretary General at RAICEX (Network of Spanish Researchers Abroad)
2017- to Sep 2019: Member from Sweden for the General Council for the Spanish Citizenship Abroad- Elected. (CGCEE- Consejo General de la Ciudadanía Española en el Exterior- Spanish Ministry for Employment and Social Security)
2017- to Sep 2019: Member of the General Council for Spanish Residents in Sweden- Elected (CRE Spanish Ministry for Foreign Affairs and Cooperation)
2017- to Sep 2019: Vicepresident of the Association of Spanish Scientists in Sweden. ACES-SFF
2014- 2017: Board member of the Association of Spanish Scientist in Sweden. ACES-SFF
2018- to Sep 2019: Member of WINGS (Women in Great Science) steering Group. LU. Sweden